Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases

References

• Avachat AM, Kapure SS. (2014). Asenapine maleate in situ forming biodegradable implant: an approach to enhance bioavailability. Int J Pharm 477:64–72.
   PubMed Web of Science ®Google Scholar
• Buoli M, Esposito CM, Godio M, et al. (2017). Have antipsychotics a different speed of action in the acute treatment of mania? A single-blind comparative study. J Psychopharmacol 31:1537–43.
   PubMed Web of Science ®Google Scholar
• Burgess DJ, Crommelin DJA, Hussain AS, Chen M-L. (2004). Assuring quality and performance of sustained and controlled released parenterals. Eur J Pharm Sci 21:679–90.
   PubMedGoogle Scholar
• Busatto C, Pesoa J, Helbling I, et al. (2018). Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: experimental and mathematical modeling. Int J Pharm 536:360–9.
   PubMed Web of Science ®Google Scholar
• Chen F, Yang L, Zhou Z, et al. (2015). Preparation and in vitro/in vivo evaluation of asenapine maleate sublingual films. Chinese Int J Pharm 46:843–855.
   Google Scholar
• Citrome LJE. (2014). Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism. Expert Opin Drug Metab Toxicol 10:893–903.
   PubMed Web of Science ®Google Scholar
• Cozar-Bernal MJ, Holgado MA, Arias JL, et al. (2011). Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation. J Microencapsul 28:430–41.
   PubMed Web of Science ®Google Scholar
• Doan TVP, Couet W, Olivier JC. (2011). Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int J Pharm 414:112–7.
   PubMed Web of Science ®Google Scholar
• Doan TVP, Olivier JC. (2009). Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Int J Pharm 382:61–6.
   PubMed Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, Axelsson A. (2011). The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-a review. Int J Pharm 415:34–52.
   PubMed Web of Science ®Google Scholar
• Husmann M, Schenderlein S, Luck M, et al. (2002). Polymer erosion in PLGA microparticles produced by phase separation method. Int J Pharm 242:277–80.
   PubMed Web of Science ®Google Scholar
• Insel TR. (2010). Rethinking schizophrenia. Nature 468:187–93.
   PubMed Web of Science ®Google Scholar
• Ito F, Honnami H, Kawakami H, et al. (2008). Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (Shirasu porous glass) membrane emulsification technique. Colloids Surf B Biointerfaces 67:20–5.
   PubMed Web of Science ®Google Scholar
• Kakazu E, Murakami T, Akamatsu K, et al. (2010). Preparation of silver nanoparticles using the SPG membrane emulsification technique. J Membr Sci 354:1–5.
   Web of Science ®Google Scholar
• Kulkarni JA, Avachat AM. (2017). Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability. Drug Dev Ind Pharm 43:234–45.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–97.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Kitazawa T, Murata J, et al. (2008). A novel preparation method for PLGA microspheres using non-halogenated solvents. J Control Release 129:223–7.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, et al. (2010). Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Affective Disord 122:27–38.
   PubMed Web of Science ®Google Scholar
• Nath SD, Son S, Sadiasa A, et al. (2013). Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration. Int J Pharm 443:87–94.
   PubMed Web of Science ®Google Scholar
• Patel MR, Hirani SN, Patel RB. (2018). Microemulsion for nasal delivery of Asenapine maleate in treatment of schizophrenia: formulation considerations. J Pharm Investig 48:301–12.
   Google Scholar
• Perugini P, Genta I, Conti B, et al. (2003). PLGA microspheres for oral osteopenia treatment: preliminary “in vitro”/“in vivo” evaluation. Int J Pharm 256:153–60.
   PubMed Web of Science ®Google Scholar
• Plosker GL, Deeks EDJCd. (2016). Asenapine: a review in schizophrenia. CNS Drugs 30:655–66.
   PubMed Web of Science ®Google Scholar
• Qi F, Wu J, Yang T, et al. (2014). Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Acta Biomater 10:4247–56.
   PubMed Web of Science ®Google Scholar
• Ramazani F, van Nostrum CF, Storm G, et al. (2016). Locoregional cancer therapy using polymer-based drug depots. Drug Discov Today 21:640–7.
   PubMed Web of Science ®Google Scholar
• Shreya AB, Managuli RS, Menon J, et al. (2016). Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations. J Liposome Res 26:221–32.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hidau MK, Gautam S, et al. (2018). Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: Pharmacokinetic and teratogenic assessment. Int J Biol Macromol 108:1092–100.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Trehan A. (2003). Biodegradable microspheres for protein delivery. J Controlled Release 90:261–80.
   PubMed Web of Science ®Google Scholar
• Suresh A, Narayan R, Nayak UY. (2020). Recent advances in the development of asenapine formulations. Expert Opin Drug Delivery. 1–17.
   PubMed Web of Science ®Google Scholar
• Takada S, Kurokawa T, Miyazaki K, et al. (1997). Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres. Pharm Res 14:1146–50.
   PubMed Web of Science ®Google Scholar
• Tarazi FI, Shahid M. (2009). Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania. Drugs Today 45:865–76.
   PubMed Web of Science ®Google Scholar
• Vaishali M, Gambhire NSR. (2019). Enhanced oral delivery of asenapine maleate from solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Asian J Pharm 12:152–61.
   Web of Science ®Google Scholar
• Van-Thanh T, Benoit J-P, Venier-Julienne M-C. (2011). Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm 407:1–11.
   PubMed Web of Science ®Google Scholar
• Vieta E, Manuel Montes J, Iborra P, et al. (2019). Management of asenapine treatment in clinical practice: Recommendations from a panel of experts. Rev Psiquiatr Salud Ment 12:163–9.
   PubMed Web of Science ®Google Scholar
• Vieta E, Montes JM. (2018). A review of asenapine in the treatment of bipolar disorder. Clin Drug Investig 38:87–99.
   PubMed Web of Science ®Google Scholar
• Wu J, Kong T, Yeung KW, et al. (2013). Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomater 9:7410–9.
   PubMed Web of Science ®Google Scholar
• Zhao H, Xu J-H, Wang T, Luo G-S. (2014). A novel microfluidic approach for preparing chitosan–silica core–shell hybrid microspheres with controlled structures and their catalytic performance. Lab Chip 14:1901–6.
   PubMed Web of Science ®Google Scholar
• Zhou X, He D, Yang J, et al. (2018). Preparation and in vitro release of asenapine maleate-loaded microspheres. Chin J New Drugs 2:17.
   Google Scholar